Neuropsychiatry

Pop psychiatry fuels misdiagnosis of autism or ADHD, delaying psychosis and bipolar treatment—why accurate labels and early meds save lives.

Early-life immigration may heighten dementia risk yet build resilience.

Adjunctive lithium sharply reduces relapse and suicidal ideation, and attempts in patients with bipolar disorder and major depressive disorder.

Data and Safety Monitoring Board finds no safety issues for buntanetap at 6 months, keeping Annovis’ phase 3 early Alzheimer disease trial on track as enrollment progresses.

Explore how glutamate and GABA balance brain excitation and inhibition, shaping development, learning, and disorders like depression, schizophrenia, and autism.

Meta-analysis reveals benefit of anti-inflammatory treatment for depression and anhedonia in individuals with inflammatory phenotype.

Review the misperceptions patients and clinicians may have about ADHD diagnosis and treatment.

Benjamin E. Yerys, PhD, shares clinical insights on the impact of the comorbidity at the APSARD Conference.

New research reveals midlife ADHD patients exhibit early Alzheimer disease biomarkers.

Explore the unique mood-stabilizing properties of antiepileptics like lamotrigine, valproic acid, and carbamazepine in bipolar disorder treatment.

Research reveals that reducing anticholinergic burden can significantly enhance cognitive function in patients with psychosis, offering new treatment insights.

Explore the complex relationship between epilepsy and psychosis, including forced normalization and treatment strategies for affected patients.

Gerald A. Maguire, MD highlights the need for psychiatric awareness and treatment of stuttering at the 2025 Southern Florida Psychiatry Conference.

Tonmya, a groundbreaking fibromyalgia treatment, is now available in the US, offering hope for millions suffering from chronic pain.

Today is World Stroke Day. Understanding what lies ahead in the road to stroke recovery can help patients and their families prepare for the challenges they will face.

Gerald A. Maguire, MD, explores the importance of understanding stuttering in psychiatry, emphasizing the need for research, collaborative care, and awareness.

Discover how advanced diagnostic tools enhance the accuracy of dementia assessments, leading to better treatment strategies and patient outcomes.

A reproductive psychiatrist discusses the implications of recent FDA announcements on medication use during pregnancy, emphasizing the importance of mental health for mothers and babies.

Explore the complex neuropsychiatric symptoms of Huntington disease and the challenges in treatment and management for affected patients.

Researchers unveil a groundbreaking nasal spray using lithium-loaded gold nanoparticles, targeting brain diseases with reduced adverse effects.

Reproductive psychiatrist Sarah Oreck, MD, MS challenges the FDA's claims linking acetaminophen use in pregnancy to autism and ADHD, advocating for informed maternal care.

Bristol Myers Squibb's BMS-986446 receives FDA Fast Track Designation, aiming to transform early Alzheimer disease treatment by targeting tau pathology.

Late-life depression poses unique challenges, impacting cognitive function and requiring tailored treatment strategies for older adults.

In this CME article, explore the complexities of movement disorders in psychiatric practice, including their causes, symptoms, and treatment strategies for better patient care.